Patents by Inventor Trudy G. Morrison

Trudy G. Morrison has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS FOR IMMUNIZING PRE-IMMUNE SUBJECTS AGAINST RESPIRATORY SYNCYTIAL VIRUS (RSV)
    Publication number: 20240082386
    Abstract: The invention provides methods for using virus-like particle (VLP) vaccines containing a stabilized pre-fusion respiratory syncytial virus (RSV) F protein to stimulate RSV neutralizing antibodies in pre-immune subjects.
    Type: Application
    Filed: November 9, 2023
    Publication date: March 14, 2024
    Inventor: Trudy G. Morrison
  • Methods for immunizing pre-immune subjects against respiratory syncytial virus (RSV)
    Patent number: 11813324
    Abstract: The invention provides methods for using virus-like particle (VLP) vaccines containing a stabilized pre-fusion respiratory syncytial virus (RSV) F protein to stimulate RSV neutralizing antibodies in pre-immune subjects.
    Type: Grant
    Filed: February 22, 2022
    Date of Patent: November 14, 2023
    Assignee: UNIVERSITY OF MASSACHUSETTS
    Inventor: Trudy G Morrison
  • METHODS FOR IMMUNIZING PRE-IMMUNE SUBJECTS AGAINST RESPIRATORY SYNCYTIAL VIRUS (RSV)
    Publication number: 20220233680
    Abstract: The invention provides methods for using virus-like particle (VLP) vaccines containing a stabilized pre-fusion respiratory syncytial virus (RSV) F protein to stimulate RSV neutralizing antibodies in pre-immune subjects.
    Type: Application
    Filed: February 22, 2022
    Publication date: July 28, 2022
    Inventor: Trudy G. Morrison
  • METHODS FOR IMMUNIZING PRE-IMMUNE SUBJECTS AGAINST RESPIRATORY SYNCYTIAL VIRUS (RSV)
    Publication number: 20210100894
    Abstract: The invention provides methods for using virus-like particle (VLP) vaccines containing a stabilized pre-fusion respiratory syncytial virus (RSV) F protein to stimulate RSV neutralizing antibodies in pre-immune subjects.
    Type: Application
    Filed: September 22, 2020
    Publication date: April 8, 2021
    Inventor: Trudy G. Morrison
  • Methods for immunizing pre-immune subjects against respiratory syncytial virus (RSV)
    Patent number: 10842862
    Abstract: The invention provides methods for using virus-like particle (VLP) vaccines containing a stabilized pre-fusion respiratory syncytial virus (RSV) F protein to stimulate RSV neutralizing antibodies in pre-immune subjects.
    Type: Grant
    Filed: September 19, 2017
    Date of Patent: November 24, 2020
    Assignee: University of Massachusetts
    Inventor: Trudy G Morrison
  • METHODS FOR IMMUNIZING PRE-IMMUNE SUBJECTS AGAINST RESPIRATORY SYNCYTIAL VIRUS (RSV)
    Publication number: 20200038503
    Abstract: The invention provides methods for using virus-like particle (VLP) vaccines containing a stabilized pre-fusion respiratory syncytial virus (RSV) F protein to stimulate RSV neutralizing antibodies in pre-immune subjects.
    Type: Application
    Filed: September 19, 2017
    Publication date: February 6, 2020
    Inventor: Trudy G Morrison
  • Respiratory synctial virus (RSV) sequences for protein expression and vaccines
    Patent number: 8580270
    Abstract: The invention provides RSV fusion (F) protein ectodomain polypeptide sequences and nucleotide sequences encoding them, as well as cells containing the invention's polypeptide and nucleotide sequences. The invention further provides VLPs that contain the invention's polypeptides, and methods for using the VLPs for protein expression and vaccine formulation. Also provided are methods for distinguishing between subjects immunized with the invention's compositions and subjects infected with RSV.
    Type: Grant
    Filed: September 30, 2009
    Date of Patent: November 12, 2013
    Assignee: University of Massachusetts
    Inventor: Trudy G. Morrison
  • RESPIRATORY SYNCTIAL VIRUS (RSV) SEQUENCES FOR PROTEIN EXPRESSION AND VACCINES
    Publication number: 20110236408
    Abstract: The invention provides RSV fusion (F) protein ectodomain polypeptide sequences and nucleotide sequences encoding them, as well as cells containing the invention's polypeptide and nucleotide sequences. The invention further provides VLPs that contain the invention's polypeptides, and methods for using the VLPs for protein expression and vaccine formulation. Also provided are methods for distinguishing between subjects immunized with the invention's compositions and subjects infected with RSV.
    Type: Application
    Filed: September 30, 2009
    Publication date: September 29, 2011
    Inventor: Trudy G. Morrison